Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date22 Feb 1988 |
|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date01 Jan 1976 |
100 Clinical Results associated with GC SHOWAYAKUHIN CORPORATION
0 Patents (Medical) associated with GC SHOWAYAKUHIN CORPORATION
100 Deals associated with GC SHOWAYAKUHIN CORPORATION
100 Translational Medicine associated with GC SHOWAYAKUHIN CORPORATION